References
Jobsen JJ, Struikmans H, Siemerink E, van der Palen J, Heijmans HJ (2022) The clinical relevance of various methods of classifying ipsilateral breast tumour recurrence as either true local recurrence or new primary. Breast Cancer Res Treat 195(3):249–262. https://doi.org/10.1007/s10549-022-06680-7
Yi M, Buchholz TA, Meric-Bernstam F, Bedrosian I, Hwang RF, Ross MI et al (2011) Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning. Ann Surg 253(3):572–579. https://doi.org/10.1097/SLA.0b013e318208fc2a
Nakagomi H, Inoue M, Hirotsu Y, Amemiya K, Mochiduki H, Omata M (2022) PIK3CA-AKT pathway predominantly acts in developing ipsilateral breast tumor recurrence long after breast-conserving surgery. Breast Cancer Res Treat. https://doi.org/10.1007/s10549-022-06570-y
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Qu, FL., Li, JJ. & Shao, ZM. Comments on: The clinical relevance of various methods of classifying ipsilateral breast tumor recurrence as either true local recurrence or new primary. Breast Cancer Res Treat 197, 243–244 (2023). https://doi.org/10.1007/s10549-022-06784-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-022-06784-0